Compare RNST & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNST | STVN |
|---|---|---|
| Founded | 1904 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Major Banks | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 1994 | 2021 |
| Metric | RNST | STVN |
|---|---|---|
| Price | $40.01 | $17.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $43.00 | $25.67 |
| AVG Volume (30 Days) | ★ 573.2K | 563.4K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.31% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.72 | $9.67 |
| Revenue Next Year | $4.67 | $9.99 |
| P/E Ratio | ★ $19.32 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.63 | $12.89 |
| 52 Week High | $42.11 | $28.00 |
| Indicator | RNST | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 60.30 | 74.51 |
| Support Level | $36.72 | $13.58 |
| Resistance Level | $39.99 | $26.94 |
| Average True Range (ATR) | 0.92 | 0.78 |
| MACD | -0.04 | 0.27 |
| Stochastic Oscillator | 48.94 | 91.61 |
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.